SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Although there are a range of drugs that can treat rheumatoid arthritis (RA), they can all have significant side effects. “Some are common and some not so common,” says Diane Horowitz, MD, an ...

Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...

Share on Pinterest A growing number of people with rheumatoid arthritis (RA) are reporting that GLP-1 drugs like Ozempic, Wegovy, and Zepbound are helping them better manage symptoms and decrease ...

Weight loss drugs known as GLP-1 receptor agonists are sometimes referred to as “miracle drugs,” not only because they help people lose weight, but because they’ve also been shown to help with many ...

In a new statement, the American Diabetes Association (ADA) has advised against the use of compounded glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic ...

More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change. (HealthDay News) — The Biden administration is proposing Medicare and Medicaid ...

People with rheumatoid arthritis (RA) may experience hair loss or thinning, though it’s not usually caused by the disease but by medications used to treat RA. Sometimes people with RA have other ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

The incoming Trump administration would need to sign off on the new legislation. (HealthDay News) — The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 ...